Business
cbdMD, Inc. Regains Compliance with NYSE American Listing Standards
cbdMD, Inc. (NYSE American: YCBD), a leading innovator in wellness and hemp-derived products, is pleased to announce that it has regained full compliance with the continued listing standards of the NYSE American. As a result, the ".BC" indicator has been removed from the list of noncompliant issuers effective at the open of trading, December 8, 2025.
About this update from Cbdmd, Inc.
[{"type":"text","content":"CHARLOTTE, N.C., Dec. 8, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leading innovator in wellness and hemp-derived products, is pleased to announce that it has regained full compliance with the continued listing standards of the NYSE American. As a result, the ".BC" indicator has been removed from the list of noncompliant issuers effective at the open of trading, December 8, 2025.","length":408,"tagName":"p"},{"type":"image","alt":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","displaySize":"","headline":null,"caption":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":172,"url":"https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Are4s7tGw9fhk38euB0v9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMwMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c","width":400,"height":172}},"href":"https://mma.prnewswire.com/media/2829180/cbdMD_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The NYSE American formally notified the Company in a letter dated December 5, 2025, confirming that cbdMD has resolved all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.","length":211,"tagName":"p"},{"type":"text","content":""We are excited to share this important news with our shareholders, partners, and team. Preserving our NYSE American listing was a critical achievement and reflects the tremendous work completed this year to strengthen our balance sheet and position the Company for sustainable growth," said Ronan Kennedy, cbdMD's CEO. "We believe our successful Series A Preferred share conversion in May and capital raise completed in September were essential components of our compliance strategy and demonstrated the commitment of our investors and stakeholders to cbdMD's long-term vision. We appreciate the NYSE American for their constructive engagement throughout this process, and we look forward to continuing to build long-term value for our shareholders as we move ahead."","length":806,"tagName":"p"},{"type":"text","content":"The Company will remain subject to NYSE American's continued listing monitoring procedures and remains committed to maintaining...